Item 8.01 Other Events
On February 10, 2021, Yumanity Therapeutics, Inc. issued a press release titled
"Yumanity Therapeutics Provides Update on its Lead Parkinson's Disease Clinical
Program, YTX-7739". A copy of the press release is attached hereto as Exhibit
99.1 and is incorporated into this Item 8.01 by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
Exhibit
No. Document
99.1 Yumanity Therapeutics, Inc. press release, dated February 10, 2021.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses